![](/img/cover-not-exists.png)
PTU-096 The use of commercial interferon-γ release assays to screen for mycobacterial infection in inflammatory bowel disease patients initiating anti-TNF agents
Greveson, K, Murray, C, Goodhand, J, Cropley, I, Murthy, S, Hamilton, M, Lipman, MVolume:
61
Language:
english
Journal:
Gut
DOI:
10.1136/gutjnl-2012-302514c.96
Date:
July, 2012
File:
PDF, 60 KB
english, 2012